Congenital adrenal hyperplasia

Search Trials
Effects of Pioglitazone in Congenital Adrenal Hyperplasia
Status:
Completed
Last Changed:
Mar 1, 2007
First Changed:
Sep 9, 2005
Disease(s):
Congenital Adrenal Hyperplasia
Intervention(s):
Pioglitazone
Growth Hormone (GH) in Congenital Adrenal Hyperplasia
Status:
Completed
Last Changed:
May 22, 2017
First Changed:
May 22, 2017
Disease(s):
Adrenal Hyperplasia, Congenital
Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia
Status:
Unknown status
Last Changed:
Dec 21, 2016
First Changed:
Jan 18, 2013
Disease(s):
Adrenal Hyperplasia, Congenital
Intervention(s):
HydrocortisoneCortisone acetate
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status:
Recruiting
Last Changed:
Sep 27, 2018
First Changed:
Sep 27, 2018
Disease(s):
Congenital Adrenal Hyperplasia
Intervention(s):
SPR001
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia
Status:
Recruiting
Last Changed:
Dec 7, 2018
First Changed:
May 16, 2018
Disease(s):
CAH - Congenital Adrenal Hyperplasia
Intervention(s):
NBI-74788

Connect. Empower. Inspire.